References
- Zarei M, Darabeigi S, Mehrpour M, Roohipoor R, Ghassemi H, Ebrahimiadib N. Fuchs’ uveitis in Iranian patients: a review of 89 eyes. Ocul Immunol Inflamm. 2019;27(7):1077–1085. doi:https://doi.org/10.1080/09273948.2018.1500612.
- Sun Y, Ji Y. A literature review on Fuchs uveitis syndrome: an update. Surv Ophthalmol. 2019;pii: . doi:https://doi.org/10.1016/jS0039-6257(19)30282–6.
- Basic and clinical science course. American academy of ophthalmology. 2019; section 9:92–93.
- Franceschetti A. Heterochromic cyclitis: Fuchs’ syndrome. Am J Ophthalmol. 1995;39:50–58.
- Liesegang TJ. Clinical features and prognosis in Fuchs’ uveitis syndrome. Arch Ophthalmol. 1982;100(10):1622–1626. doi:https://doi.org/10.1001/archopht.1982.01030040600009.
- Jones NP. Fuchs’ heterochromic uveitis: a reappraisal of the clinical spectrum. Eye. 1991;5(Pt 6):649–661. doi:https://doi.org/10.1038/eye.1991.121.
- Bouchenaki N, Herbort CP. Fuchs’ uveitis: failure to associate vitritis and disc hyperfluorescence with the disease is the major factor for misdiagnosis and diagnostic delay. Middle East Afr J Ophthalmol. 2009;16(4):239–244. doi:https://doi.org/10.4103/0974-9233.58424.
- Tugal-Tutkun I, Guney-Tefekli E, Kamaci-Duman F, Corum I. A cross-sectional and longitudinal study of Fuchs uveitis syndrome in Turkish patients. Am J Ophthalmol. 2009;148(4):510–515.e511. doi:https://doi.org/10.1016/j.ajo.2009.04.007.